- Home
- WASH vs PLRX Comparison
WASH vs PLRX Comparison
Compare WASH & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- PLRX
- Stock Information
- Founded
- WASH 1800
- PLRX 2015
- Country
- WASH United States
- PLRX United States
- Employees
- WASH N/A
- PLRX N/A
- Industry
- WASH Major Banks
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- WASH Finance
- PLRX Health Care
- Exchange
- WASH Nasdaq
- PLRX Nasdaq
- Market Cap
- WASH 542.9M
- PLRX 84.7M
- IPO Year
- WASH N/A
- PLRX 2020
- Fundamental
- Price
- WASH $29.65
- PLRX $1.29
- Analyst Decision
- WASH Buy
- PLRX Hold
- Analyst Count
- WASH 4
- PLRX 10
- Target Price
- WASH $32.25
- PLRX $9.79
- AVG Volume (30 Days)
- WASH 146.9K
- PLRX 1.5M
- Earning Date
- WASH 07-21-2025
- PLRX 08-06-2025
- Dividend Yield
- WASH 7.55%
- PLRX N/A
- EPS Growth
- WASH N/A
- PLRX N/A
- EPS
- WASH N/A
- PLRX N/A
- Revenue
- WASH $110,088,000.00
- PLRX N/A
- Revenue This Year
- WASH $57.46
- PLRX N/A
- Revenue Next Year
- WASH $9.82
- PLRX N/A
- P/E Ratio
- WASH N/A
- PLRX N/A
- Revenue Growth
- WASH N/A
- PLRX N/A
- 52 Week Low
- WASH $24.95
- PLRX $1.10
- 52 Week High
- WASH $40.59
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- WASH 67.16
- PLRX 43.30
- Support Level
- WASH $27.43
- PLRX $1.13
- Resistance Level
- WASH $28.25
- PLRX $1.43
- Average True Range (ATR)
- WASH 0.68
- PLRX 0.11
- MACD
- WASH 0.27
- PLRX -0.01
- Stochastic Oscillator
- WASH 93.29
- PLRX 37.57
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.